Acurx Pharmaceuticals ACXP Stock
Acurx Pharmaceuticals Price Chart
Acurx Pharmaceuticals ACXP Financial and Trading Overview
| Acurx Pharmaceuticals stock price | 1.77 USD |
| Previous Close | 3.62 USD |
| Open | 3.67 USD |
| Bid | 3.67 USD x 2200 |
| Ask | 3.87 USD x 1100 |
| Day's Range | 3.52 - 3.93 USD |
| 52 Week Range | 1.17 - 8.82 USD |
| Volume | 205.48K USD |
| Avg. Volume | 746.23K USD |
| Market Cap | 50.94M USD |
| Beta (5Y Monthly) | -1.609 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.33 USD |
ACXP Valuation Measures
| Enterprise Value | 43.89M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.2045455 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 12.211221 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Acurx Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -1.609 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 8.82 USD |
| 52 Week Low | 1.17 USD |
| 50-Day Moving Average | 3.17 USD |
| 200-Day Moving Average | 2.88 USD |
ACXP Share Statistics
| Avg. Volume (3 month) | 746.23K USD |
| Avg. Daily Volume (10-Days) | 216.49K USD |
| Shares Outstanding | 13.77M |
| Float | 11.31M |
| Short Ratio | 0.51 |
| % Held by Insiders | 18.97% |
| % Held by Institutions | 8.78% |
| Shares Short | 946.11K |
| Short % of Float | 9.77% |
| Short % of Shares Outstanding | 7.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -87.85% |
| Return on Equity (ttm) | -185.77% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -12723689 USD |
| Diluted EPS (ttm) | -1.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.05M USD |
| Total Cash Per Share (mrq) | 0.51 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.221 |
| Book Value Per Share (mrq) | 0.303 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7098696 USD |
| Levered Free Cash Flow (ttm) | -2327313 USD |
Profile of Acurx Pharmaceuticals
| Country | United States |
| State | NY |
| City | Staten Island |
| Address | 259 Liberty Avenue |
| ZIP | 10305 |
| Phone | 917 533 1469 |
| Website | https://www.acurxpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. It is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. The company was incorporated in 2017 and is headquartered in Staten Island, New York.
Q&A For Acurx Pharmaceuticals Stock
What is a current ACXP stock price?
Acurx Pharmaceuticals ACXP stock price today per share is 1.77 USD.
How to purchase Acurx Pharmaceuticals stock?
You can buy ACXP shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Acurx Pharmaceuticals?
The stock symbol or ticker of Acurx Pharmaceuticals is ACXP.
Which industry does the Acurx Pharmaceuticals company belong to?
The Acurx Pharmaceuticals industry is Biotechnology.
How many shares does Acurx Pharmaceuticals have in circulation?
The max supply of Acurx Pharmaceuticals shares is 15.76M.
What is Acurx Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Acurx Pharmaceuticals PE Ratio is now.
What was Acurx Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Acurx Pharmaceuticals EPS is -1.15 USD over the trailing 12 months.
Which sector does the Acurx Pharmaceuticals company belong to?
The Acurx Pharmaceuticals sector is Healthcare.
Acurx Pharmaceuticals ACXP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}